KinoGlu: A Chemical Strategy to illuminate CNS Biology
Lead Research Organisation:
University of Dundee
Department Name: School of Life Sciences
Abstract
Many neurodegenerative illnesses have no effective treatments that address the cause of the disease. The chemistry currently used to treat these diseases accesses specific protein targets in the brain and typically, attempts to block them. These approaches have had a high clinical failure rate due to not working as hoped in humans. Developing new chemistry that can generate knowledge and treatment options that function differently are therefore needed.
Targeted Protein Degradation is the method I will use to address this problem. This area of research is revolutionising chemical biology and drug discovery research. Cancer has been the early benefactor, but I wish to extend this to neurodegenerative and other Central Nervous System related diseases.
Collectively, over 1 million people have Alzheimer's and Parkinson's Disease in the UK. Both diseases are progressive and have no cure. Generating chemical research tools that enable new treatment discoveries for these diseases would provide substantive societal benefit.
This project will for the first time provide a rational method for designing and discovering molecules that can glue and degrade disease-causing proteins. This strategy will address critical issues relevant to this therapeutic area such as:
- The specific protein expression patterns that may affect how Targeted Protein Degradation can be utilised to treat diseases in the brain.
- Challenges associated with treatments reaching the brain
- Selective chemical tools that can be used to robustly validate new therapeutic concepts
To deliver my project I will make a toolbox of molecules that can bind to a group of therapeutically important proteins, Protein Kinases. These chemical tools will be able to glue disease causing protein kinases to other proteins that are part of the natural cell disposal system. The disease-causing proteins will be destroyed, returning the cell to health with no damage to healthy proteins. I will study how these tools behave in neuronal cells and use the findings as starting points to discover potent and selective kinase degrader glues.
More broadly, this project will produce chemical tools and a design approach that will be useful to many scientists. They will provide knowledge about how proteins interact with each other, both in a cellular and an in vitro environment.
Targeted Protein Degradation is the method I will use to address this problem. This area of research is revolutionising chemical biology and drug discovery research. Cancer has been the early benefactor, but I wish to extend this to neurodegenerative and other Central Nervous System related diseases.
Collectively, over 1 million people have Alzheimer's and Parkinson's Disease in the UK. Both diseases are progressive and have no cure. Generating chemical research tools that enable new treatment discoveries for these diseases would provide substantive societal benefit.
This project will for the first time provide a rational method for designing and discovering molecules that can glue and degrade disease-causing proteins. This strategy will address critical issues relevant to this therapeutic area such as:
- The specific protein expression patterns that may affect how Targeted Protein Degradation can be utilised to treat diseases in the brain.
- Challenges associated with treatments reaching the brain
- Selective chemical tools that can be used to robustly validate new therapeutic concepts
To deliver my project I will make a toolbox of molecules that can bind to a group of therapeutically important proteins, Protein Kinases. These chemical tools will be able to glue disease causing protein kinases to other proteins that are part of the natural cell disposal system. The disease-causing proteins will be destroyed, returning the cell to health with no damage to healthy proteins. I will study how these tools behave in neuronal cells and use the findings as starting points to discover potent and selective kinase degrader glues.
More broadly, this project will produce chemical tools and a design approach that will be useful to many scientists. They will provide knowledge about how proteins interact with each other, both in a cellular and an in vitro environment.
| Description | LITE Consortia Member as Co-Principal Investigator |
| Amount | $305,430 (USD) |
| Organisation | Michael J Fox Foundation |
| Sector | Charity/Non Profit |
| Country | United States |
| Start | 01/2025 |
| End | 12/2026 |
| Description | Hosted undergraduate summer school student for 8 week research experience |
| Form Of Engagement Activity | Participation in an open day or visit at my research institution |
| Part Of Official Scheme? | No |
| Geographic Reach | Regional |
| Primary Audience | Undergraduate students |
| Results and Impact | In line with original grant workplan, an 8 week summer placement was provided for an undergraduate student to gain experience experience in a real-world research environment. |
| Year(s) Of Engagement Activity | 2024 |
| Description | Hosting of 8 week undergraduate summer school student |
| Form Of Engagement Activity | Participation in an open day or visit at my research institution |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Undergraduate students |
| Results and Impact | In line with original grant workplan, an 8 week summer placement was provided for an undergraduate student to gain experience experience in a real-world research environment. |
| Year(s) Of Engagement Activity | 2023 |
| Description | Hosting of school summer placement student |
| Form Of Engagement Activity | Participation in an open day or visit at my research institution |
| Part Of Official Scheme? | No |
| Geographic Reach | Local |
| Primary Audience | Schools |
| Results and Impact | Hosted a school student for a 2 week research visit to help them to understand life in a research environment and help to inform on their higher education choices. |
| Year(s) Of Engagement Activity | 2024 |
| Description | Patient Research Interest Group workshop |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | Regional |
| Primary Audience | Patients, carers and/or patient groups |
| Results and Impact | Around 50 Parkinsons Disease patients who are part of the Parkinson's UK research interest group attended a day of lab tours and talks at the University of Dundee School of Life Sciences. As part of this I engaged with a 'communciating science' excercise whereby I worked over a period of a few months with the carer of a patient to help them understand the work my group does to devleop better chemical tools for neurodegenerative dieases. She then presented our research group and research goals to other patients and carers. My team and I also led tours and public engagement activiites within the centre for targeted protein degradation. |
| Year(s) Of Engagement Activity | 2024 |
